Alnylam Pharmaceuticals
ALNY
#438
Rank
C$73.67 B
Marketcap
C$557.66
Share price
2.35%
Change (1 day)
62.08%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company